Gaurav D. Shah
2018
In 2018, Gaurav D. Shah earned a total compensation of $6.4M as President and Chief Executive Officer at Inotek Pharmaceuticals.
Compensation breakdown
| Bonus | $300,940 |
|---|---|
| Option Awards | $5,651,220 |
| Salary | $413,735 |
| Other | $9,857 |
| Total | $6,375,752 |
Shah received $5.7M in option awards, accounting for 89% of the total pay in 2018.
Shah also received $300.9K in bonus, $413.7K in salary and $9.9K in other compensation.
Rankings
In 2018, Gaurav D. Shah's compensation ranked 1,435th out of 14,244 executives tracked by ExecPay. In other words, Shah earned more than 89.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,435 out of 14,244 | 90th |
Division Manufacturing | 500 out of 5,765 | 91st |
Major group Chemicals And Allied Products | 155 out of 2,128 | 93rd |
Industry group Drugs | 122 out of 1,817 | 93rd |
Industry Pharmaceutical Preparations | 90 out of 1,391 | 94th |
Source: SEC filing on April 30, 2019.
Shah's colleagues
We found three more compensation records of executives who worked with Gaurav D. Shah at Inotek Pharmaceuticals in 2018.